Mycobacterial Treatment Flashcards
Characteristics of Mycobacteria Shape Stain Replication location Growth pace May form? Cell walls are rich in?
Rod shaped Acid fast stain...they don't gram stain Replicate within macrophages Generally slow growing May form filaments Lipid-rich cell walls
Most infected individuals have what kind of infections?
Latent infections
Transmission is primarily through
Respiratory droplets
When may TB become disseminated?
In immunocompromised individuals
Features of latent TB infections activation state chest xray sputum and cultures symptom presentation infectious state case or not
Inactive and non-replicating Chest xray normal Sputum and cultures are negative Asymptomatic Not infectious Not a case of TB
Features of TB disease activation state chest xray sputum and cultures symptom presentation infectious state case or not
Active and replicating Abnormal chest xray Sputum and cultures MAY be positive Symptomatic Often infectious before treatment A case of TB
Obstacles to TB Treatment
organism grows slowly
organism remains viable but dormant
rapid development of resistance
toxicity with treatment–encourages non-compliance
Solutions to obstacles
Regimens contain multiple drugs
Drugs taken regularly
Drug therapy continues for long time
Rifamycin MOA
Inhibits RNA synthesis
Streptomycin MOA
useful for
Inhibition of protein synthesis at 30S
Used for combination treatment of RESISTANT TB
Isoniazid and ethionamide MOA
inhibit mycolic acid synthesis
Ethambutol MOA
Inhibits cell wall synthesis
Pyrazinamide MOA
Inhibits membrane synthesis
M. avium complex (MAC) causes pulmonary disease and disseminated disease in which populations
Pulmonary disease in immunocompetent patients
Disseminated disease in immunocompromised patients, mainly AIDS patient population
MAC primarily acquired through which route?
Ingestion of contaminated food and water
Preferred Regimen (4 drugs)
Isoniazid
Rifamycin
Pyrazinamide
Ethambutol